Asthma & COPD II

With the proliferation of chronic lung conditions, pharmaceutical companies and research institutions need to continuously find new innovative therapeutic solutions. Inseparable from the issues concerning Asthma, the problems associated with Chronic Obstructive Pulmonary Disease (COPD) are striking. These diseases combined, form one of the biggest potential killers in the coming decades.

SMi’s Asthma & COPD II Conference will uncover the latest developments in clinical research and uncover new advances delivery technologies. Special emphasis will be given to problems being faced in a global market, the acceleration of new drug concepts, the similarities and differences in the two diseases, as well as the various drug classes assigned to combat progressive symptoms.